Urinary Tract Infection Market Research Report—Forecast till 2027

admin — Thu, 18 Mar 2021 02:16:03 +0000

Market Overview
Global Urinary Tract Infections Market is anticipated to exhibit a CAGR of 3.62% during the review period of 2020 to 2027. The infection in urinary system parts such as kidneys, ureters, bladder, and urethra are referred to as urinary tract infection. The major causes of UTI infection are unsafe sex, lack of hygiene, and diabetes.
Global Urinary Tract Infections Market is expected to register the highest market growth owing to the largest market value of USD 9,490.88 Million in 2019. As per the World Health Organization, 1 million hospitalizations of women occur each year due to UTIs, which affect almost half the female population around the world. Urological health issues are more common in diabetic patients. An increasing prevalence of diabetic population is expected to boost the global UTI patients worldwide. However, complex regulatory requirements are anticipated to restrain the growth of the global urinary tract infection market during the review period.
Market Segmentation
Global Urinary Tract Infections Market has been segmented into Drug Class, Application, Pathogen, End User.
In terms of drug class, the market has been classified into quinolones, β-lactam & cephalosporins, aminoglycosides, penicillin, and azoles. The quinolones segment is further sub-divided into ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, and fleroxacin. The cephalosporin is again classified into avycaz, cedax, cefdinir, and cefditoren. The β-lactam is further divided into amoxicillin-clavulanate, cefdinir, cefaclor, and cefpodoxime-proxetil.
The Global Urinary Tract Infections Market, based on application, has been divided into urethritis, cystitis, and pyelonephritis. In terms of the pathogen, the market has been categorized into Escherichia coli, Staphylococcus saprophyticus, Klebsiella pneumoniae, Proteus mirabilis, and Enterococcus faecalis. By end-user category, the global urinary tract infections market has been classified into hospitals, clinics, self-administered, and others.
Regional Analysis
Geographically, the global UTI market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to dominate the global market owing to the largest market share of 33.6% of the global market in 2019. The regional market growth is driven by the presence of key manufacturers, the increasing prevalence of urinary tract infections, and the increasing aging woman population in the region. The market in the Americas is categorized into North America and Latin America. Additionally, the global market growth is driven by the increasing technological advancements in diagnostics and therapeutic products coupled with the rising prevalence of urinary tract diseases and other kidney problems.
Europe is expected to register the second-largest market of the Global Urinary Tract Infection. The regional market is segmented into France, Germany, Italy, Spain, and the UK. The regional market growth is attributed to the increasing awareness of urinary tract diseases, increasing educational activity, and the availability of different diagnostic and therapeutic methods to manage the infection. Asia-Pacific is set to exhibit the fastest-growing market for UTI during the review period. The regional market growth is driven by the developing economies and highly populated countries such as China, India, and South Korea.
Major Players
The Prominent Players in the Global Urinary Tract Infections Market are Pfizer Inc., Novo Nordisk A/S, Novartis Ag, Merck & Co., Inc., Eli Lily and Company, Allergan, Cipla Inc., Teva Pharmaceuticals, GlaxoSmithKline plc, and Bayer AG.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Urinary Tract Infection Market Research Report—Forecast till 2027 first appeared on CRI Report.

Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023

admin — Fri, 04 Jan 2019 05:53:05 +0000

Market Analysis
With the increasing problems of malnutrition and poor health, it has become very much important for people to get hold of the best dietary supplements. These supplements are consumed to increase the level of consumption. These supplements have biological benefits if consumed regularly. The supplements generally include those substances that are beneficial to health, like fiber, amino acids, minerals, vitamins, fatty acids, and other substances. The global dietary supplements in the age of personalized nutrition market are expected to grow at a CAGR of 6.90% during the forecast period 2017-2023.
One of the main driving forces that are affecting the growth of this market is an individual lifestyle and changing food habits of the people. Fluctuation in the nutrition content of the food is also another factor that is affecting the market. In the age of personalized nutrition, the dietary supplements are considered to be the major reasons for drastic changes in the healthcare sector due to its ability to offer one with improvised drug delivery system along with better patient care or individual treatment process. Advancements made in the preparation of the dietary supplements along with the superior drug formulation processes is expected to uplift the global dietary supplements in the age of personalized nutrition market.
Market Segmentation
The global dietary supplements in the age of personalized nutrition market are categorized on the basis of its product category, gender, application, end user, dosage form and regional demand. Based on its product category, the market is segmented into herbs & botanicals, vitamins, sports supplements, minerals, meal supplements, and others. Based on its gender, the global dietary supplements in the age of personalized nutrition market is segmented into male and female. On the basis of its application, the global market is classified into lifestyle diseases, genetic predispositions, inherited diseases, and others. On the basis of its dosage form, the market is sectioned into tablets, powder, soft gels, capsules, liquids, and others. Based on its end users, the market is divided into home care, hospitals & clinics, and others.
Regional Analysis
Geographically, the global dietary supplements in the age of personalized nutrition market are divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of the major players in the global dietary supplements in the age of personalized nutrition market include companies like Nestlé Health Science, Carlyle Group, Danone Nutricia, Amway (Nutrilite), Abbott Laboratories, Archer Daniels Midland, Herbalife International, Danisco, Amway, Glanbia, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Balchem Corporation, Bactolac Pharmaceutical Inc., Natures Product Inc., among others.

The post Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023 first appeared on CRI Report.

GlaxoSmithKline plc – CRI Report

Urinary Tract Infection Market Research Report—Forecast till 2027

Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023